Clinical Lab 2.0 places labs at the forefront of better healthcare delivery, through an innovative new business model.
The world of healthcare is changing – the clinical laboratory is changing with it. While the traditional, transactional lab model continues to serve as a foundation, the emerging Clinical Lab 2.0 business model leverages longitudinal laboratory data to produce actionable, clinical insight, driving better outcomes for patients, providers, and financial stakeholders alike.
Clinical Lab 2.0 re-engineers the role of lab in the care continuum, aligning with the future of value-based healthcare.
Improving Global Healthcare Through Clinical Lab 2.0
Lab 2.0: Lab Leadership’s Link to Patient Outcomes
In this recorded webinar from the CDC Division of Laboratory Systems, James M. Crawford, M.D., Ph.D. discusses how the Clinical Laboratory is being recognized as necessary and foundational to patient care and public health, and is the key to getting the COVID-19 Pandemic in check.
Heard in the industry
“Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation”
Journal of Applied Laboratory Medicine
“An intriguing and stimulating chance to meet with thought leaders and interact with other executives facing the need to reorient their labs to a value-based perspective”
“Project Santa Fe is a coalition of like-minded major regional laboratories, coming together to create and help drive the new frontiers”